US Stock MarketDetailed Quotes

CARM Carisma Therapeutics

Watchlist
  • 0.860
  • -0.015-1.69%
Trading Nov 19 14:37 ET
35.91MMarket Cap-562P/E (TTM)

Carisma Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
-11.55%3.39M
158.34%9.2M
4.75%3.4M
51.71%14.92M
14.96%4.29M
48.45%3.83M
31.71%3.56M
294.53%3.24M
9.83M
3.73M
Operating revenue
-11.55%3.39M
158.34%9.2M
4.75%3.4M
51.71%14.92M
14.96%4.29M
48.45%3.83M
31.71%3.56M
294.53%3.24M
--9.83M
--3.73M
Cost of revenue
Gross profit
Operating expense
-36.84%16.53M
-14.92%20.87M
-12.62%22.91M
57.05%103.65M
40.34%26.74M
35.40%26.17M
47.42%24.53M
138.80%26.22M
61.78%66M
19.05M
Selling and administrative expenses
-21.40%5.2M
-7.44%5.56M
-43.13%5.45M
214.83%29.53M
654.27%7.32M
75.50%6.62M
147.81%6.01M
333.02%9.57M
46.37%9.38M
--971K
-General and administrative expense
-21.40%5.2M
-7.44%5.56M
-43.13%5.45M
214.83%29.53M
654.27%7.32M
75.50%6.62M
147.81%6.01M
333.02%9.57M
46.37%9.38M
--971K
Research and development costs
-42.07%11.33M
-17.34%15.31M
4.93%17.46M
30.92%74.13M
7.37%19.42M
25.67%19.55M
30.30%18.52M
89.81%16.64M
64.65%56.62M
--18.08M
Operating profit
41.17%-13.14M
44.34%-11.67M
15.07%-19.51M
-57.99%-88.73M
-46.52%-22.45M
-33.39%-22.34M
-50.47%-20.97M
-126.19%-22.97M
-37.67%-56.16M
-15.32M
Net non-operating interest income expense
-53.03%442K
-56.84%508K
136.02%532K
161.56%1.94M
249.37%1.3M
203.63%941K
252.66%1.18M
-146.58%-1.48M
-31,550.00%-3.15M
-867K
Non-operating interest income
----
----
----
--1.94M
----
----
----
----
----
----
Non-operating interest expense
----
----
----
----
----
----
----
----
--3.15M
----
Total other finance cost
53.03%-442K
56.84%-508K
-136.02%-532K
----
----
-203.63%-941K
-252.66%-1.18M
146.58%1.48M
----
----
Other net income (expense)
95.62%-84K
0
84.92%-84K
-1.92M
-550K
Gain on sale of security
----
----
----
95.62%-84K
--0
----
----
84.92%-84K
---1.92M
---550K
Income before tax
40.65%-12.7M
43.59%-11.16M
22.64%-18.98M
-41.90%-86.88M
-26.38%-21.16M
-16.78%-21.4M
-33.27%-19.79M
-116.88%-24.53M
-50.12%-61.23M
-16.74M
Income tax
0
0
0
0
88K
109K
Net income
40.65%-12.7M
43.84%-11.16M
22.99%-18.98M
-41.90%-86.88M
-25.20%-20.96M
-16.78%-21.4M
-33.86%-19.88M
-117.84%-24.64M
-50.12%-61.23M
-16.74M
Net income continuous Operations
40.65%-12.7M
43.84%-11.16M
22.99%-18.98M
-41.90%-86.88M
-25.20%-20.96M
-16.78%-21.4M
-33.86%-19.88M
-117.84%-24.64M
-50.12%-61.23M
---16.74M
Minority interest income
Net income attributable to the parent company
40.65%-12.7M
43.84%-11.16M
22.99%-18.98M
-41.90%-86.88M
-25.20%-20.96M
-16.78%-21.4M
-33.86%-19.88M
-117.84%-24.64M
-50.12%-61.23M
-16.74M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
40.65%-12.7M
43.84%-11.16M
22.99%-18.98M
-41.90%-86.88M
-25.20%-20.96M
-16.78%-21.4M
-33.86%-19.88M
-117.84%-24.64M
-50.12%-61.23M
-16.74M
Basic earnings per share
41.51%-0.31
44.90%-0.27
76.17%-0.46
-70.29%-2.59
-15.43%-0.48
-16.41%-0.53
-32.84%-0.49
-586.81%-1.93
-50.12%-1.521
-0.4158
Diluted earnings per share
41.51%-0.31
44.90%-0.27
76.17%-0.46
-70.29%-2.59
-15.43%-0.48
-16.41%-0.53
-32.84%-0.49
-586.81%-1.93
-50.12%-1.521
-0.4158
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue -11.55%3.39M158.34%9.2M4.75%3.4M51.71%14.92M14.96%4.29M48.45%3.83M31.71%3.56M294.53%3.24M9.83M3.73M
Operating revenue -11.55%3.39M158.34%9.2M4.75%3.4M51.71%14.92M14.96%4.29M48.45%3.83M31.71%3.56M294.53%3.24M--9.83M--3.73M
Cost of revenue
Gross profit
Operating expense -36.84%16.53M-14.92%20.87M-12.62%22.91M57.05%103.65M40.34%26.74M35.40%26.17M47.42%24.53M138.80%26.22M61.78%66M19.05M
Selling and administrative expenses -21.40%5.2M-7.44%5.56M-43.13%5.45M214.83%29.53M654.27%7.32M75.50%6.62M147.81%6.01M333.02%9.57M46.37%9.38M--971K
-General and administrative expense -21.40%5.2M-7.44%5.56M-43.13%5.45M214.83%29.53M654.27%7.32M75.50%6.62M147.81%6.01M333.02%9.57M46.37%9.38M--971K
Research and development costs -42.07%11.33M-17.34%15.31M4.93%17.46M30.92%74.13M7.37%19.42M25.67%19.55M30.30%18.52M89.81%16.64M64.65%56.62M--18.08M
Operating profit 41.17%-13.14M44.34%-11.67M15.07%-19.51M-57.99%-88.73M-46.52%-22.45M-33.39%-22.34M-50.47%-20.97M-126.19%-22.97M-37.67%-56.16M-15.32M
Net non-operating interest income expense -53.03%442K-56.84%508K136.02%532K161.56%1.94M249.37%1.3M203.63%941K252.66%1.18M-146.58%-1.48M-31,550.00%-3.15M-867K
Non-operating interest income --------------1.94M------------------------
Non-operating interest expense ----------------------------------3.15M----
Total other finance cost 53.03%-442K56.84%-508K-136.02%-532K---------203.63%-941K-252.66%-1.18M146.58%1.48M--------
Other net income (expense) 95.62%-84K084.92%-84K-1.92M-550K
Gain on sale of security ------------95.62%-84K--0--------84.92%-84K---1.92M---550K
Income before tax 40.65%-12.7M43.59%-11.16M22.64%-18.98M-41.90%-86.88M-26.38%-21.16M-16.78%-21.4M-33.27%-19.79M-116.88%-24.53M-50.12%-61.23M-16.74M
Income tax 000088K109K
Net income 40.65%-12.7M43.84%-11.16M22.99%-18.98M-41.90%-86.88M-25.20%-20.96M-16.78%-21.4M-33.86%-19.88M-117.84%-24.64M-50.12%-61.23M-16.74M
Net income continuous Operations 40.65%-12.7M43.84%-11.16M22.99%-18.98M-41.90%-86.88M-25.20%-20.96M-16.78%-21.4M-33.86%-19.88M-117.84%-24.64M-50.12%-61.23M---16.74M
Minority interest income
Net income attributable to the parent company 40.65%-12.7M43.84%-11.16M22.99%-18.98M-41.90%-86.88M-25.20%-20.96M-16.78%-21.4M-33.86%-19.88M-117.84%-24.64M-50.12%-61.23M-16.74M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 40.65%-12.7M43.84%-11.16M22.99%-18.98M-41.90%-86.88M-25.20%-20.96M-16.78%-21.4M-33.86%-19.88M-117.84%-24.64M-50.12%-61.23M-16.74M
Basic earnings per share 41.51%-0.3144.90%-0.2776.17%-0.46-70.29%-2.59-15.43%-0.48-16.41%-0.53-32.84%-0.49-586.81%-1.93-50.12%-1.521-0.4158
Diluted earnings per share 41.51%-0.3144.90%-0.2776.17%-0.46-70.29%-2.59-15.43%-0.48-16.41%-0.53-32.84%-0.49-586.81%-1.93-50.12%-1.521-0.4158
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data